Surprised that some of the interest in UCG prompted by Linc's deals have not rubbed off on Cougar's sp. Market seems to have priced the chances of Cougar pulling of a similar deal as zero. Maybe too pessimistic?
Not a whole lot of companies around the world with pilot plant experience to compete against, I would have thought.
Chances of a Lazarus with a triple bypass recovery cannot be ruled out totally. Something for the patient to consider.
Surprised that some of the interest in UCG prompted by Linc's...
Add to My Watchlist
What is My Watchlist?